|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2011-1-26
|
|
pubmed:abstractText |
Myasthenia gravis (MG) is an autoimmune disease with weakness in striated musculature due to anti-acetylcholine receptor (AChR) antibodies or muscle specific kinase at the neuromuscular junction. A subgroup of patients has periocular symptoms only; ocular MG (OMG). Matrix metalloproteinases (MMP) are increased in several autoimmune diseases, including generalized MG (GMG), and have been suggested to play a role in immune cell infiltration, basement membrane breakdown and autoimmune pathogenesis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1421-9913
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright © 2011 S. Karger AG, Basel.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
65
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
53-8
|
|
pubmed:meshHeading |
pubmed-meshheading:21212676-Autoantibodies,
pubmed-meshheading:21212676-Autoantigens,
pubmed-meshheading:21212676-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:21212676-Female,
pubmed-meshheading:21212676-Humans,
pubmed-meshheading:21212676-Male,
pubmed-meshheading:21212676-Matrix Metalloproteinase 2,
pubmed-meshheading:21212676-Matrix Metalloproteinase 3,
pubmed-meshheading:21212676-Matrix Metalloproteinase 9,
pubmed-meshheading:21212676-Middle Aged,
pubmed-meshheading:21212676-Myasthenia Gravis,
pubmed-meshheading:21212676-Receptors, Cholinergic
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Matrix metalloproteinases in myasthenia gravis.
|
|
pubmed:affiliation |
Department of Clinical Medicine, University of Bergen, Bergen, Norway. geir.helgeland@gmail.com
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
